• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 13.56
  • VXN 16.73
  • VXO 14.00
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





YES
Refresh      
PRGO (Perrigo Company plc)
Last Trade 49.24 Dividend/Share 0.76 PE Ratio 10.85
Date March 19-2019 Dividend Yield 1.562 Return on Assets 1.18
Change 0.57 ExDividend Date 2019-02-28 Return on Capital null
Bid 0 Latest EPS 0.93 Price/Sale 1.398
Ask 0 LatestEPS Date 2018-12-31 Price to Book 1.17
Volume 20724 EPS ttm 4.540 Institutional % 132.2
Avg Volume 1.37M Shares Outstanding 135.87M Insider % null
Open 48.9 Float 135M Short Ratio 5.780
Prev Close 48.67 Return On Equity 2.26 5 Year Change % -0.689
High 49.5 Consensus EPS 0.98 2 Year Change % -0.265
Low 48.8 No. of Estimate 12.000 1 Year Change % -0.394
52 Week High 84.94 EPS Surprise $ null YTD Change % 0.221
52 Week Low 36.28 EPS Surprise Percent -1.0204 6 Month Change % -0.321
52 Week Change -41.515 EBITDA 0M 3 Month Change % -0.107
50 Day MA 46.86814 Revenue 0M 1 Month Change % -0.002
200 Day MA Gross Profit 0M 5 Day Change % 0.031
Market Cap 6612.94M Cash 0M 30 Day Change % 0.056
Beta 1.317743 Debt 0M Stock Exchange New York Stock Exchange
Sector Healthcare Revenue Per Share 0 Short Interest 8186014
Short Date 2019-02-28 Revenue Per Employee 0 Short Ratio 5.780
Data courtesy of IEX
12
Company Profile

Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API), and medical diagnostic products worldwide. The company operates through three segments: Consumer Healthcare, Rx Pharmaceuticals, and API. The Consumer Healthcare segment offers OTC pharmaceutical and nutritional products, which include analgesic, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, first aid, and vitamin and nutritional supplement products. The Rx Pharmaceuticals segment develops, manufactures, and markets generic prescription drug products, including creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquid suspensions, and solutions, as well as nasal sprays, oral liquids, and transdermal products. The API segment engages in the development, manufacture, and marketing of APIs used by the generic drug industry and branded pharmaceutical companies. Perrigo Company also manufactures and markets branded prescription drugs; and imports pharmaceutical, diagnostics, and other medical products. The company has collaborative agreements with Medicis Pharmaceutical Corporation, Medimetriks Pharmaceuticals, Cobrek Pharmaceuticals, and Cephalon Inc. Its customers primarily include retail drug companies, supermarkets, wholesalers, chain drug stores, hospitals and hospital systems, mass merchandise chains, and group purchasing organizations. The company was founded in 1887 and is headquartered in Allegan, Michigan.